Impact of prior treatment on PFS for relapsed/refractory mantle cell lymphoma patients randomized to lenalidomide vs investigator's choice: a subgroup analysis of the phase II Mcl-002 (Sprint) study.
Trneny, M Lamy, T Walewski, J Belada, D Mayer, J Jurczak, W Morschhauser, F Alexeeva, J Rule, S
Trneny, M
Lamy, T
Walewski, J
Belada, D
Mayer, J
Jurczak, W
Morschhauser, F
Alexeeva, J
Rule, S
Citations
Altmetric:
Abstract
Description
Date
2015
Publisher
Collections
Keywords
Type
Meetings and Proceeding
Citation
Impact of prior treatment on PFS for relapsed/refractory mantle cell lymphoma patients randomized to lenalidomide vs investigator's choice: a subgroup analysis of the phase II Mcl-002 (Sprint) study. 2015, 100: 4 Haematologica